Ipca Laboratories Ltd

BSE Code : 524494
NSE Symbol : IPCALAB
ISIN : INE571A01038
Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

Trade Now

Get Quotes

1,310.30 -4.50(-0.34%)

Open Price (₹)

1,319.00

Prev. Close (₹)

1,314.80

Volume (No’s)

108,722

Market Cap (₹)

33,242.86

Low Price (₹)

1,301.70

High Price (₹)

1,321.90

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Profit and Loss

	Mar 2025 (₹.Cr)	Mar 2024 (₹.Cr)	Mar 2023 (₹.Cr)	Mar 2022 (₹.Cr)	Mar 2021 (₹.Cr)	Mar 2020 (₹.Cr)
INCOME :
Sales Turnover	6,677.92	6,166.46	5,814.62	5,438.30	5,139.16	4,367.43
Excise Duty	0.00	0.00	0.00	0.00	0.00	29.61
Net Sales	6,677.92	6,166.46	5,814.62	5,438.30	5,139.16	4,337.82
Other Income	71.29	111.29	111.19	52.92	62.24	64.69
Stock Adjustments	-128.43	55.19	-104.09	126.00	170.73	155.05
Total Income	6,620.78	6,332.94	5,821.72	5,617.22	5,372.13	4,557.56
EXPENDITURE :
Raw Materials	1,764.88	2,033.57	1,964.94	1,911.88	1,753.21	1,635.75
Power & Fuel Cost	235.60	253.33	277.21	237.44	201.48	196.82
Employee Cost	1,479.34	1,336.19	1,193.39	1,102.14	948.84	870.79
Other Manufacturing Expenses	367.61	356.81	311.74	279.03	225.25	198.30
Selling & Administrative Expenses	953.42	846.95	812.67	612.89	551.23	523.99
Miscellaneous Expenses	503.13	314.87	236.31	179.67	113.31	149.41
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	5,303.98	5,141.72	4,796.26	4,323.05	3,793.32	3,575.06
Operating Profit	1,316.80	1,191.22	1,025.46	1,294.17	1,578.81	982.50
Interest	65.06	122.58	46.34	10.41	11.13	18.84
Gross Profit	1,251.74	1,068.64	979.12	1,283.76	1,567.68	963.66
Depreciation	251.97	246.48	228.63	209.65	187.72	178.69
Profit Before Tax	999.77	822.16	750.49	1,074.11	1,379.96	784.97
Tax	340.90	288.01	223.95	197.28	244.98	137.98
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	8.11	3.74	20.84	16.46	-5.79	-5.47
Reported Net Profit	650.76	530.41	505.70	860.37	1,140.77	652.46
Extraordinary Items	-169.55	-69.52	17.51	7.86	8.34	10.86
Adjusted Net Profit	820.31	599.93	488.19	852.51	1,132.43	641.60
Adjustment below Net Profit	-4.92	-1.39	-2.05	1.15	-0.16	-107.04
P & L Balance brought forward	4,956.80	4,478.52	4,076.35	3,316.31	2,277.18	1,752.53
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	101.48	50.74	101.48	101.48	101.48	20.77
P & L Balance carried down	5,501.16	4,956.80	4,478.52	4,076.35	3,316.31	2,277.18
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	400.00	400.00	400.00	400.00	400.00	250.00
Dividend Per Share(Rs)	4.00	4.00	4.00	4.00	8.00	5.00
Earnings Per Share-Unit Curr	25.65	20.91	19.93	33.91	89.93	51.64
Earnings Per Share(Adj)-Unit Curr	25.65	20.91	19.93	33.91	44.97	25.82
Book Value-Unit Curr	271.64	250.24	231.66	215.84	374.67	290.11
Book Value(Adj)-Unit Curr	271.64	250.24	231.66	215.84	187.34	145.06